Prescription ·Strong evidence ·Reviewed May 2026
Prescription niacin is nicotinic acid (vitamin B3) used at gram-level doses far above the nutritional requirement to treat dyslipidemia. It lowers triglycerides and LDL cholesterol while raising HDL cholesterol, but its routine use has declined because large outcome trials (AIM-HIGH, HPS2-THRIVE) did not show added cardiovascular benefit when combined with statins and raised safety concerns. Available as immediate-release and extended-release tablets, it carries a high burden of flushing, hepatotoxicity, and worsened glycemic control.
The bottom line
Evidence rating strong. Most-documented uses: lowers elevated triglycerides, lowers ldl cholesterol, raises hdl cholesterol. 3 sources indexed (2011–2018), with 6 interaction records on file.
Core mechanism
At pharmacologic doses niacin inhibits hepatic diacylglycerol acyltransferase-2 (DGAT2), reducing triglyceride synthesis and VLDL secretion, which in turn lowers LDL and Lp(a). It also decreases lipolysis in adipose tissue, partly through activation of the GPR109A (HM74A) receptor, reducing free fatty acid flux to the liver. The same GPR109A activation in skin Langerhans cells triggers prostaglandin D2 release, causing the characteristic cutaneous flushing. Niacin additionally slows hepatic clearance of apolipoprotein A-I, raising HDL.1,2
Water-soluble. Extended-release niacin should be taken at bedtime after a low-fat snack to reduce flushing and GI upset. High-fat meals and alcohol or hot beverages near dosing worsen flushing. Immediate-release and extended-release forms are NOT interchangeable on a milligram basis because of differing hepatotoxicity profiles.3
Nutrients this medication can lower over time, and what to replace.
High-dose nicotinic acid is a component of glucose tolerance factor and influences chromium handling; pharmacologic niacin therapy has been associated with increased urinary chromium excretion and altered chromium status. This is mechanistically linked to niacin's well-documented tendency to impair insulin sensitivity and worsen glycemic control, and chromium repletion has been studied as a way to mitigate niacin-induced glucose intolerance. Evidence for clinically meaningful depletion is limited and inconsistent.
Concentrated green tea extract has been associated with liver injury, which can complicate use of hepatotoxic drugs such as Niacin (Prescription).
Recommendation: Avoid high-dose green tea extract during therapy or use only with clinician review, especially if liver enzymes are abnormal or symptoms of hepatitis occur.
Berberine may lower glucose, while prescription niacin can worsen glycemic control; combining them can make glucose response less predictable.
Recommendation: Monitor fasting glucose or A1c when starting or stopping either agent.
Niacin (nicotinic acid) is a B-vitamin (vitamin B3). High-dose prescription niacin overlaps with niacin supplements and is sometimes combined with other B-vitamins in supplement regimens. There is no clinically significant pharmacologic interaction between vitamin B6 (pyridoxine) and nicotinic acid, but patients taking prescription niacin should avoid stacking additional high-dose niacin-containing B-complex products, since unintentional dose duplication can increase flushing and hepatotoxicity risk.
Recommendation: Vitamin B6 can be taken with prescription niacin without a specific timing requirement. Review any B-complex or multivitamin to ensure it does not add a substantial dose of niacin/nicotinic acid on top of the prescribed amount, and report severe flushing, nausea, or signs of liver injury to a clinician.
High-dose prescription niacin, especially sustained- or extended-release formulations, can cause dose-dependent hepatotoxicity ranging from transaminase elevations to fulminant hepatic injury. Milk thistle (silymarin) is widely used for hepatoprotection. Patients should not rely on milk thistle to prevent niacin-induced liver injury, and concurrent use can complicate interpretation of liver enzyme changes.
Recommendation: Continue scheduled liver function monitoring while on prescription niacin regardless of milk thistle use. Do not use silymarin as a substitute for dose limits or LFT surveillance. Report dark urine, jaundice, right upper quadrant pain, or unexplained fatigue promptly.
Prescription niacin causes prostaglandin-mediated cutaneous flushing (warmth, redness, itching), the most common reason for discontinuation. Quercetin has been studied as an anti-inflammatory and mast-cell-stabilizing flavonoid. Combining them is generally low risk, but quercetin is not an established treatment for niacin flushing and should not replace proven measures such as aspirin pretreatment or slow titration.
Recommendation: Manage niacin flushing with evidence-based strategies (low-dose aspirin 30 minutes before dosing, taking with food, avoiding hot beverages and alcohol near dosing, gradual dose escalation). Quercetin may be taken concurrently but should not be relied on for flush control.
Prescription niacin and fish oil (omega-3 fatty acids EPA/DHA) both lower triglycerides through complementary mechanisms and are sometimes used together for hypertriglyceridemia. The combination is generally well tolerated, though both can have mild effects on glucose and platelet function, so monitoring is still appropriate.
Recommendation: Concurrent use can be reasonable for triglyceride lowering under clinician guidance. Monitor lipids and, in diabetic patients, glucose. There is no required dose separation. Watch for additive bruising or bleeding tendency if other antiplatelet or anticoagulant agents are also used.
Search all 6 interaction records for Niacin (Prescription) →
Numbered references. Citations throughout the page link here.
No reduction in vascular events with significant excesses of diabetes-related, gastrointestinal, musculoskeletal, infection, and bleeding adverse events.
Extended-release niacin raised HDL and lowered triglycerides but provided no incremental clinical benefit over statin therapy alone and the trial was stopped early.
Label documents dose-related flushing, transaminase elevations requiring monitoring, worsened glycemic control, and elevated uric acid.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
